Vascular Endothelial Growth Factor Peptide Ligands Explored by Competition Assay and Isothermal Titration Calorimetry
Authors:
- Marie Reille-SeroussiMRMarie Reille-Seroussi
- Jean-François GaucherJGJean-François Gaucher
- Claudia DesoleCDClaudia Desole
- Nathalie Gagey-EilsteinNGNathalie Gagey-Eilstein
- Franck BrachetFBFranck Brachet
- Isabelle BroutinIsabelle Broutin
- Michel VidalMVMichel Vidal
- Sylvain BroussySylvain Broussy
- 13 August 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 54 (33) , 5147-5156
Abstract
The v114* cyclic peptide has been identified as a tight vascular endothelial growth factor (VEGF) ligand. Here we report on the use of isothermal titration calorimetry (ITC), 96-well plate competition assay, and circular dichroism (CD) to explore the binding determinants of a new set of related peptides. Anti-VEGF antibodies are currently used in the clinic for regulating angiogenesis in cancer and age-related macular degeneration treatment. In this context, our aim is to develop smaller molecular entities with high affinity for the growth factor by a structure activity relationship approach. The cyclic disulfide peptide v114* was modified in several ways, including truncation, substitution, and variation of the size and nature of the cycle. The results indicated that truncation or substitution of the four N-terminal amino acids did not cause severe loss in affinity, allowing potential peptide labeling. Increase of the cycle size or substitution of the disulfide bridge with a thioether linkage drastically decreased the affinity, due to an enthalpy penalty. The leucine C-terminal residue positively contributed to affinity. Cysteine N-terminal acetylation induced favorable ΔΔG° and ΔΔH° of binding, which correlated with free peptide CD spectra changes. We also propose a biochemical model to extrapolate Ki from IC50 values measured in the displacement assay. These calculated Ki correlate well with the Kd values determined by extensive direct and reverse ITC measurements.Keywords
Funding Information
- ARC (France) (DOC2013 0606849)
- National Research Agency (France) (ANR-2010-BLAN-1533-03)
This publication has 39 references indexed in Scilit:
- The Development of Peptide-Based Tools for the Analysis of AngiogenesisChemistry & Biology, 2011
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Molecular recognition at protein surface in solution and gas phase: Five VEGF peptidic ligands show inverse affinity when studied by NMR and CID‐MSPeptide Science, 2010
- Bacterial display enables efficient and quantitative peptide affinity maturationProtein Engineering, Design and Selection, 2009
- Vascular Endothelial Growth FactorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factorJournal of Molecular Biology, 2002
- Angiogenesis in cancer and other diseasesNature, 2000
- Novel Peptides Selected to Bind Vascular Endothelial Growth Factor Target the Receptor-Binding SiteBiochemistry, 1998